OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

NEXI S.P.A./  IT0005366767  /

Berlin
2024-09-18  8:08:12 AM Chg. +0.264 Volume Bid7:43:13 AM Ask7:43:13 AM Market Capitalization Dividend Y. P/E Ratio
6.338EUR +4.35% 0
Turnover: 0.000		 6.430Bid Size: 810 6.492Ask Size: 810 8.39 bill.EUR - -
GlobeNewswire 06-25 Worthington Enterprises Increases Quarterly Dividend by 6.25%
GlobeNewswire 06-12 Worthington Enterprises Schedules Fourth Quarter 2024 Earnings Call for June 26
GlobeNewswire 06-03 Worthington Enterprises Completes Acquisition of Hexagon Ragasco
GlobeNewswire 2023-10-24 NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
GlobeNewswire 2023-10-19 NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
GlobeNewswire 2023-10-18 NexImmune Announces 1-for-25 Reverse Stock Split
GlobeNewswire 2023-09-29 Calian Launches Digital Health Portfolio of Products and Services
GlobeNewswire 2023-09-28 Northland Power Announces Financial Close of the 1.0 GW Hai Long Offshore Wind Project in Taiwan Fin...
GlobeNewswire 2023-08-31 NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development ...
GlobeNewswire 2022-03-17 NexImmune and Zephyr AI Announce a Strategic Partnership in Oncology for Target Discovery and Valida...
GlobeNewswire 2022-03-14 NexImmune Announces Melanoma Research Collaboration with NYU Langone’s Perlmutter Cancer Center
GlobeNewswire 2022-03-10 NexImmune to Present at the Barclays 2022 Global Healthcare Conference
GlobeNewswire 2022-03-09 NexImmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
GlobeNewswire 2022-02-17 NexImmune Appoints Kristi Jones as Chief Executive Officer and Member of the Board of Directors
GlobeNewswire 2022-01-05 NexImmune Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board
GlobeNewswire 2021-12-12 NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma
GlobeNewswire 2021-11-12 NexImmune Reports Third Quarter 2021 Financial Results and Provides Business Updates
GlobeNewswire 2021-11-08 NexImmune to Announce Third Quarter 2021 Financial Results and Provide Corporate Update on November ...
GlobeNewswire 2021-11-03 NexImmune to Present at The Society for Immunotherapy of Cancer 36th Anniversary Annual Meeting
GlobeNewswire 2021-10-20 Bottomline Appoints Three New Directors to Board of Directors
GlobeNewswire 2021-09-27 NexImmune to Present at the 2021 Cantor Virtual Global Healthcare Conference
GlobeNewswire 2021-09-16 SBM Offshore completes US$1.6 billion financing of Sepetiba
GlobeNewswire 2021-09-10 NexImmune to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
GlobeNewswire 2021-08-18 Aite-Novarica Group Announces Winners of the 2021 Digital Wallet Innovation Awards
GlobeNewswire 2021-08-09 NexImmune Reports Second Quarter 2021 Financial Results and Provides Business Updates